Advertisement Biomarker Analysis Using Monolithic Integrated Multiplexing Micro-Opto-Fluidics - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Biomarker Analysis Using Monolithic Integrated Multiplexing Micro-Opto-Fluidics

CASE STUDIES
By

PLC Diagnostics Inc. developed a novel, rapid
diagnostic testing platform for sensitive, robust,
inexpensive and simple detection of molecular
biomarkers.

This new platform is based on novel microarray chip technology that replaces the expensive laser scanning. Use is made of an array with a monolithic integrated intersecting grid of 100 μm wide planar integrated optical waveguides.

This technology enables real-time quantification of molecular complex formation on the microarray surface, without reagent addition or washes. This significantly reduces assay complexity and cost so that the platform can be used in Point-of-Care (POC) settings.

Quick Contact


Top Products from